Latest news with #Post-COVID-19
Newsweek
28-05-2025
- Business
- Newsweek
Air Conditioning Warning Issued as Temperatures Heat Up
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. As summer temperatures begin to rise across the country, a headache is also heating up for the air conditioning industry. A shortage of R-454B refrigerant, the eco-friendly coolant poised to replace older formulas, is threatening to disrupt cooling systems at the worst possible time. Why It Matters Manufacturers have issued warnings about potential legal and damage concerns about mixing refrigerants as a means to circumvent the shortages. A mechanic working on an outdoor air conditioner in Orlando, Florida, on October 13, 2022. A mechanic working on an outdoor air conditioner in Orlando, Florida, on October 13, 2022. Wirestock/Getty Images What Is R-454B Refrigerant? R-454B is a next-generation refrigerant developed to replace R-410A in heating, ventilation and air conditioning (HVAC) systems. Its composition results in a refrigerant with a significantly lower global warming potential than older refrigerants, making it less environmentally harmful. Why Is There a Shortage? According to heating and cooling specialist Aristotle Air, the shortage of R-454B refrigerant is primarily due to a combination of regulatory changes, supply chain disruptions and increased demand. The Environmental Protection Agency's (EPA) American Innovation and Manufacturing Act of 2020 mandated the use of refrigerants with a global warming potential of 750 or less by January 1, 2025. R-454B, with a global warming potential of 466, has been adopted by major HVAC manufacturers as the standard replacement for R-410A, Aristotle Air said, adding that the EPA's mandate sparked a "surge" in installations. It also reported a lack of the specialized cylinders required for R-454B, which has bottlenecked distribution. Post-COVID-19 logistic disruptions and raw material shortages have additionally limited R-454B output, and contractors, anticipating shortages, have been hoarding R-454B, further exacerbating scarcity, Aristotle Air added. Warnings While most U.S. HVAC manufacturers chose R-454B for new systems, some brands have opted for R-32. Daikin warned customers about strict EPA and Department of Energy rules on refrigerant mixing as a strategy to mitigate the shortages. "Using R-32 in an R-454B unit is not only against manufacturers' recommendations, due to differences in their chemical compositions and operating characteristics, it is also illegal," the firm said in a notice issued to customers, according to The ACHR News. "Unless an alternative has been approved by EPA's Significant New Alternatives Policy (SNAP) program (and the necessary system modifications have been made), each HVAC unit is designed for a specific refrigerant, and using a different refrigerant can lead to malfunctions or damages," the notice continued. What People Are Saying Jason Gassmann, the owner of Bell Brothers Heating & AC, told WHO 13: "The supply chain is going to be an issue if you didn't prepare for it because you won't be able to fix problems with new systems that people have paid for. That will be a huge issue as far as the pricing and stuff. Yes, the tariffs have affected the price of a cylinder of this refrigerant, because we are low on supply. It has gone up exponentially, which obviously impacts the financials of a business, which is which is hard on us." Representative Marjorie Taylor Greene, a Republican from Georgia, wrote on X, formerly Twitter, on Tuesday: "R-410A which has been an incredibly reliable and inexpensive refrigerant is being phased out and R-454B is the new refrigerant that everyone has to buy, but can barely find. The shortage and supply of R-454B is driving the cost as high as $1,000 dollars for a 20 pound jug compared to an avg cost of $300 for a 25 pound jug of R-410A." What Happens Next The shortages could pose a concern as summer approaches and temperatures across the country begin to rise, increasing demand for cooling. Forecasters at AccuWeather are anticipating potentially record-breaking temperatures in some Western states Thursday through Saturday.
Associated Press
02-03-2025
- Health
- Associated Press
CORRECTION FROM SOURCE: AI to Transform Independent and Assisted Living With Addison Virtual Caregiver
The Competitive Edge in AI-Powered Senior Living Correction: The 'About...' Section needed to be updated to reflect both Electronic Caregiver and Addison Care. As well as some grammar/spelling corrections. LAS CRUCES, NEW MEXICO / ACCESS Newswire / March 1, 2025 / As the market demands excellence in resident care, Addison Care is revolutionizing independent and assisted living with its AI-powered virtual care solution. Offering unmatched support, safety, retention, and profitability, Addison Care empowers senior living communities to improve resident outcomes while reducing operational risks at just $8 per day. In a landscape where nearly all residents manage multiple chronic conditions and anywhere from 7 to 14 medications, treatment non-adherence accounts for 50% of health setbacks. Addison Care's 24/7 care management tackles this head-on, monitoring medication schedules and daily routines to extend functional lifespan and quality of life. 'Our goal is to help residents live longer, happier, and more comfortably,' says Erika Ruiz, COO at Electronic Caregiver, Inc., 'We're closing the backdoor of resident turnover-saving operators $12,000 to $15,000 per lost resident.' Post-COVID-19, infectious disease remains a top concern, with influenza and other illnesses historically plaguing communal living. Addison Care's advanced monitoring identifies early signs of infection, enabling swift isolation to prevent outbreaks in dining rooms and common areas. This proactive approach protects communities and restores family confidence shaken by past pandemics. 'The senior living industry has a great responsibility to ensure their residents are safe, secure, and supported, especially with consideration to the high number of those living with multiple chronic illnesses, complex treatment regimens, and at higher risk of falls, accidents, and infectious disease exposure,' said Anthony Dohrmann, CEO of Electronic Caregiver, Inc., and inventor of Addison Care. Loneliness, often called the silent killer, compounds these challenges as aging residents hesitate to report falls, symptoms, or side effects that'll burden loved ones or reveal declining abilities. Addison Care counters this with 24/7 companionship, delivering games, entertainment, and cognitive stimulation. Noninvasive AI Wi-Fi tracks sleep and movement, while family apps provide real-time updates, fostering engagement and transparency. Safety leaps forward with Addison's four-way emergency response system, on-screen touch, wrist wearables, and mobile GPS-replacing outdated pull cords and glitch-prone pendants that contribute to preventable mortalities and escalations. Early detection of health anomalies ensures rapid response to accidents and emergencies, keeping residents secure across the property. Negative chatter, a byproduct of resident deaths or departures, erodes trust as families question negligence and safety. Addison Care's proactive oversight minimizes these events, reducing liabilities and preserving the community's reputation. 'When residents thrive, families notice,' adds Dohrmann. 'We're not just enhancing care-we're strengthening bonds.' At $8/day (.34/hour) with a small one-time equipment fee, Addison Care delivers affordable excellence without extra staff or infrastructure. Managed by Addison's 3D Virtual Caregiver and telecare team, it integrates seamlessly with property staff, doctors, and families - freeing operators to focus on community, not healthcare logistics. Optional resident-pay programs even turn care into a revenue stream. Implementation is effortless: Addison provisions all technology conducts resident classes, provides ongoing support, and coordinates launch PR events to boost brand visibility. 'Traditional communities excel at filling units but lose revenue due to inadequate safety and health oversight,' says Dohrmann. 'Addison Care fixes that, keeping residents healthier, happier, and in place longer.' With Addison Care, senior living operators gain a competitive edge by elevating care, engagement, and trust while stabilizing income. The future of senior living starts today. About Electronic Caregiver Electronic Caregiver, the leader in innovative virtual care solutions, proudly offers Addison Care - an AI-developed platform designed to revolutionize senior living. With 24/7 support, enhanced safety features, and cost-effective care management, Addison Care empowers independent and assisted living communities to meet the growing demand for excellence. For more information, visit or call 833-324-5433 (Sales ext. 1).
Yahoo
17-02-2025
- Business
- Yahoo
Driven by Rising Demand for Biologics & Personalized Medicine – Latest Report by TMR
The global biotech API manufacturing services market, valued at US$ 38.9 Bn in 2022, is anticipated to grow at a CAGR of 7.1% and exceed US$ 73 Bn by 2031. Factors such as increasing demand for innovative drugs, the prevalence of chronic diseases, and the growing trend toward personalized medicine are driving this growth. Post-COVID-19, the market has seen heightened demand for biologics and biosimilars, opening new opportunities for manufacturers leveraging digital technologies. Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 17, 2025 (GLOBE NEWSWIRE) -- Biotech API Manufacturing Services Market Overview The global biotech API manufacturing services market, valued at US$ 38.9 Billion in 2022, is projected to grow at a CAGR of 7.1% from 2023 to 2031, surpassing US$ 73 Billion by 2031. biotech API manufacturing services market The global market is poised for significant growth, fueled by a surge in demand for innovative and effective drugs. As chronic diseases become more prevalent and the global geriatric population continues to rise, the need for advanced pharmaceutical solutions has never been greater. Biotech APIs, known for their efficacy and specificity, are at the forefront of this evolution. The increasing adoption of biologics and biosimilars, coupled with a rising trend toward personalized medicine, is driving the demand for biotech API manufacturing services. This growth is further supported by technological advancements in API process development, regulatory support, and analytical testing & quality control. For more insights, Request a sample report: API Manufacturing Services Industry Overview The biotech API manufacturing services industry plays a crucial role in pharmaceutical development, offering specialized services that include API process development & manufacturing, analytical testing & quality control, regulatory support, and scale-up & commercial manufacturing. With the rising complexity of drug formulations and an increasing focus on precision medicine, the industry is witnessing robust demand for advanced biotech APIs. Post the COVID-19 pandemic, there has been a marked increase in demand for biologics and biosimilars, particularly for the treatment of COVID-19 patients. This has paved the way for new opportunities within the market. Furthermore, the integration of digital technologies, such as remote monitoring and virtual collaboration, is reshaping the industry, allowing manufacturers to enhance their market share and global presence. Key Players and Their Latest Developments Prominent players in the biotech API manufacturing services market include: Lonza Group WuXi AppTec Samsung Biologics Boehringer Ingelheim GmbH FUJIFILM Diosynth Biotechnologies AGC Biologics Amgen Inc. Cytovance Biologics Avid Bioservices Inc. These companies are focusing on strategic collaborations, expansion of manufacturing facilities, and integration of advanced digital technologies to maintain their competitive edge. For instance, Samsung Biologics recently announced an expansion of its manufacturing facility to cater to the growing demand for biologics. Similarly, Lonza Group has invested in digital technologies to enhance operational efficiency and customer engagement. Key Strategies Adopted by Market Players in the Biotech API Manufacturing Services Market 1. Expansion of Manufacturing Capabilities Leading companies are investing in large-scale production facilities to meet the growing demand for biologics, biosimilars, and cell & gene therapies. Example: Samsung Biologics and WuXi Biologics have expanded their global footprint with new biologics manufacturing plants in Asia, Europe, and North America. 2. Strategic Partnerships & Collaborations Biotech API manufacturers are forming alliances with pharmaceutical companies, research organizations, and biotech startups to accelerate drug development and commercialization. Example: Lonza and Moderna partnered to support large-scale mRNA vaccine production during the COVID-19 pandemic. 3. Adoption of Advanced Bioprocessing Technologies Companies are integrating single-use bioreactors, AI-driven process automation, and continuous manufacturing to enhance production efficiency and scalability. Example: Thermo Fisher Scientific is leveraging AI and digital twins to optimize biopharmaceutical manufacturing. 4. Mergers & Acquisitions (M&A) for Market Expansion Leading biotech API manufacturers are acquiring smaller firms to expand expertise, increase production capacity, and strengthen service offerings. Example: Thermo Fisher Scientific acquired Patheon to expand its end-to-end biologics development and manufacturing services. Get Customized Insights & Analysis for Your Business Needs: Growth and Market Scope The biotech API manufacturing services market is witnessing substantial growth due to increasing demand for biologics and biosimilars, particularly in oncology and autoimmune disease treatment. The growing inclination toward personalized medicine, which requires specialized APIs, is further propelling market growth. The industry's scope extends to various sectors, including: API Process Development & Manufacturing – With a focus on efficient and scalable production methods. Analytical Testing & Quality Control – Ensuring compliance with stringent regulatory standards. Regulatory Support – Assisting pharmaceutical companies in navigating complex approval processes. Scale-up & Commercial Manufacturing – Enabling mass production while maintaining quality and efficacy. Top Market Trends Rise of Personalized Medicine: The increasing demand for tailored treatments is driving the need for biotech APIs that cater to individual patient requirements. Surge in Biologics & Biosimilars: The growing adoption of biologics and biosimilars for chronic diseases and cancer treatments is propelling market demand. Integration of Digital Technologies: The adoption of digital tools for remote monitoring, predictive maintenance, and virtual collaboration is enhancing operational efficiency. Sustainability and Eco-friendly Solutions: Manufacturers are increasingly focusing on sustainable practices, including green manufacturing and waste reduction. Impact on the Consumer Industry The consumer industry is significantly impacted by advancements in biotech API manufacturing services. The rise of biologics and personalized medicine means that consumers now have access to more effective and targeted treatments. Furthermore, the enhanced safety and efficacy of biotech APIs have increased patient compliance and satisfaction. The demand for eco-friendly and sustainable solutions is also influencing consumer choices, pushing manufacturers to adopt greener practices. This trend is particularly evident in developed markets, where environmental consciousness is driving purchasing decisions. Segments and Regions Service Type: API Process Development & Manufacturing Analytical Testing & Quality Control Regulatory Support Scale-up & Commercial Manufacturing Region: North America Europe Asia Pacific Latin America Middle East & Africa Future Outlook The global biotech API manufacturing services market is on a trajectory of robust growth, driven by the increasing demand for innovative and effective drugs, the rising prevalence of chronic diseases, and the growing trend toward personalized medicine. With the integration of digital technologies and a focus on sustainable practices, the industry is set to redefine pharmaceutical manufacturing in the coming years. As key players continue to innovate and expand their capabilities, the market is poised to offer unprecedented opportunities for growth and investment. With a projected valuation of over US$ 73 Bn by 2031, the biotech API manufacturing services market remains a lucrative space for stakeholders and investors. Purchase the Full Market Report Today: Why to Buy This Biotech API Manufacturing Services Market Research Report 1. Comprehensive Market Insights Gain a detailed understanding of the global biotech API manufacturing services market, including key growth drivers, challenges, and opportunities. Analyze market size, revenue forecasts, and emerging trends shaping the industry. 2. Competitive Landscape & Key Player Strategies Identify leading biotech API manufacturers, their market share, and strategic initiatives. Learn about mergers & acquisitions, technological advancements, and partnership trends among major players like Lonza, WuXi Biologics, Samsung Biologics, and Catalent. 3. Emerging Technologies & Innovations Understand how AI-driven automation, single-use bioreactors, and continuous bioprocessing are transforming API manufacturing. Evaluate the role of sustainability and green manufacturing in reducing costs and environmental impact. 4. Market Segmentation & Industry Applications Get insights into different biotech API types, including monoclonal antibodies, recombinant proteins, vaccines, and gene therapy APIs. Explore how industries like pharmaceuticals, biotechnology firms, and contract development & manufacturing organizations (CDMOs) are leveraging API services. 5. Regulatory & Compliance Landscape Stay updated on FDA approvals, GMP compliance, and evolving regulatory frameworks in different regions. Learn how companies navigate stringent quality control requirements to ensure safe and effective biotech APIs. 6. Investment & Expansion Opportunities Discover growth hotspots, key investment areas, and potential revenue streams in biotech API manufacturing. Identify emerging markets and untapped opportunities for expansion. 7. Data-Driven Decision Making Access detailed market analytics, competitive benchmarking, and industry forecasts to support strategic business decisions. Use the report to evaluate partnerships, market entry strategies, and investment plans effectively. Explore Latest Research Reports by Transparency Market Research: Agricultural Biotechnology Market - Global Market is expected to reach value of US$ 64.7 Billion by the end of 2031 AI in Pharma and Biotech Market - Expected to grow at a CAGR of 18.8% from 2024 to 2034 and reach US$ 13.1 Billion by the end of 2034 About Transparency Market Research Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information. Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. Contact: Transparency Market Research HEADQUARTER DOWNTOWN,1000 N. West Street,Suite 1200, Wilmington, Delaware 19801 USATel: +1-518-618-1030USA – Canada Toll Free: 866-552-3453Website: Email: sales@ Us: LinkedIn| Twitter| Blog | YouTubeSign in to access your portfolio
